Back to Search Start Over

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion

Authors :
Benjamin Besse
Lizza E.L. Hendriks
Thierry Berghmans
Antonin Levy
Dirk De Ruysscher
Johan Vansteenkiste
Matteo Giaj Levra
Baktiar Hasan
Niccolò Giaj Levra
Silvia Novello
Christophe Dooms
Anne-Marie C. Dingemans
Pulmonologie
Promovendi ODB
MUMC+: MA Med Staf Spec Longziekten (9)
RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Radiotherapie
Source :
European Journal of Cancer, 123, 28-35. ELSEVIER SCI LTD, European journal of cancer, 123
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Abstract

Synchronous oligometastatic non-small cell lung cancer (NSCLC) definition varies from 1 metastasis in 1 organ (tumour-node-metastasis 8 [TNM8]), 1-3 metastases (European Society for Medical Oncology [ESMO]), ≤3 metastases (including mediastinal nodes [MLN]) after systemic treatment to 3-5 metastases in ongoing trials. A single definition is however needed to design/compare trials. To assess oligometastatic NSCLC definitions used by clinical experts in daily practice and its evolution, we redistributed a 2012 case-based survey (Dooms, the World Congress of Lung Cancer 2013).<br />info:eu-repo/semantics/published

Details

ISSN :
09598049
Volume :
123
Database :
OpenAIRE
Journal :
European Journal of Cancer
Accession number :
edsair.doi.dedup.....cce4cf853845d75a700d64fafc7a23d6